Cargando…
Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar
OBJECTIVES: The aim of the study was to determine whether it is safe to stop secondary prophylaxis in patients with talaromycosis after immune reconstitution with a sustained increase in CD4 count to ≥ 100 cells/µL after antiretroviral therapy (ART). METHODS: A retrospective cohort analysis was perf...
Autores principales: | Tun, N, Mclean, A, Deed, X, Hlaing, M, Aung, Y, Wilkins, E, Ashley, E, Smithuis, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590157/ https://www.ncbi.nlm.nih.gov/pubmed/32741092 http://dx.doi.org/10.1111/hiv.12921 |
Ejemplares similares
-
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
por: Warrell, Clare E., et al.
Publicado: (2021) -
Evaluation of the forum theatre approach for public engagement around antibiotic use in Myanmar
por: Swe, Myo Maung Maung, et al.
Publicado: (2020) -
Melioidosis in Myanmar
por: Win, Mo Mo, et al.
Publicado: (2018) -
Malaria community health workers in Myanmar: a cost analysis
por: Kyaw, Shwe Sin, et al.
Publicado: (2016) -
Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar
por: Tun, Ni Ni, et al.
Publicado: (2023)